Peter N. Reikes
Directeur/Membre du Conseil chez Heart & Soul Foundation
Profil
Peter N.
Reikes is currently the Director of Heart & Soul Foundation.
He previously worked as Vice Chairman & Head-Healthcare Investment Banking at Cowen & Co. LLC from 1999 to 2010, Vice Chairman-Healthcare Investment Banking at Stifel, Nicolaus & Co., Inc. from 2010 to 2012, and MD & Head-Healthcare Investment Banking at PaineWebber, Inc. from 1985 to 1998.
He also served as a Director at Alkermes, Inc., Cephalon, Inc., Repligen Corp., Ionis Pharmaceuticals, Inc., SICOR, Inc., Genzyme Corp., Concord Biosciences LLC, and Biocompatibles UK Ltd.
He completed his undergraduate studies at the University of California, Los Angeles and earned an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Peter N. Reikes
| Sociétés | Poste | Début |
|---|---|---|
| Heart & Soul Foundation | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter N. Reikes
| Sociétés | Poste | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/11/2021 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Corporate Officer/Principal | 26/10/2010 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Corporate Officer/Principal | 30/09/2010 |
| PaineWebber, Inc. | Corporate Officer/Principal | 31/12/1998 |
Biocompatibles UK Ltd.
 Biocompatibles UK Ltd. BiotechnologyHealth Technology Biocompatibles UK Ltd. manufactures and markets implantable products for patients. Biocompatibles UK Ltd. is based in Farnham, UK and has subsidiaries in the UK. It was founded in 2001. | Directeur/Membre du Conseil | - |
Formation de Peter N. Reikes
| University of California, Los Angeles | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Health Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Finance |
| PaineWebber, Inc. | Finance |
Concord Biosciences LLC
 Concord Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Concord Biosciences LLC provides preclinical contract research services that offers drug development to pharmaceutical and biotechnology companies. It drug safety, bio analytical services, concord agrochemicals, and commercial services. The company was founded in 1986 and is headquartered in Concord, OH. | Commercial Services |
Biocompatibles UK Ltd.
Biocompatibles UK Ltd. BiotechnologyHealth Technology Biocompatibles UK Ltd. manufactures and markets implantable products for patients. Biocompatibles UK Ltd. is based in Farnham, UK and has subsidiaries in the UK. It was founded in 2001. | Health Technology |
| Heart & Soul Foundation |